Hackeng T M, Maurissen L F A, Castoldi E, Rosing J
Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
J Thromb Haemost. 2009 Jul;7 Suppl 1:165-8. doi: 10.1111/j.1538-7836.2009.03363.x.
Protein S is an anticoagulant cofactor of full-length tissue factor pathway inhibitor (TFPI) that facilitates optimal factor Xa-inhibition and efficient down-regulation of thrombin generation in plasma. Protein S and TFPI are constitutively active in plasma and therefore provide an effective anticoagulant barrier against unwanted procoagulant activity in the circulation. In this review, we describe the current status on how TFPI-activity depends on protein S, and show that TFPI and protein S are major regulators of thrombin generation both in the absence and presence of activated protein C (APC). As there is covariation of plasma TFPI and protein S levels both in health and in disease, these findings suggest that the risk of venous thrombosis associated with protein S deficiency states might be in part explained by the accompanying low plasma TFPI levels.
蛋白S是全长组织因子途径抑制剂(TFPI)的抗凝辅助因子,可促进血浆中因子Xa的最佳抑制以及凝血酶生成的有效下调。蛋白S和TFPI在血浆中具有组成性活性,因此可提供有效的抗凝屏障,抵御循环中不必要的促凝活性。在本综述中,我们描述了TFPI活性如何依赖于蛋白S的现状,并表明TFPI和蛋白S在活化蛋白C(APC)存在和不存在的情况下都是凝血酶生成的主要调节因子。由于健康和疾病状态下血浆TFPI和蛋白S水平都存在协变,这些发现表明,与蛋白S缺乏状态相关的静脉血栓形成风险可能部分归因于伴随的低血浆TFPI水平。